Vi Partners Secures €161M First Close for New Venture Fund

Why It Matters

The capital injection strengthens Europe’s VC pipeline, giving founders critical early funding in high‑growth sectors. It also signals confidence in Swiss innovation ecosystems, potentially attracting more limited‑partner capital to the region.

Key Takeaways

• €161M first close marks Vi Partners' 25th anniversary.
• Fund targets Series A tech and healthcare startups.
• Emphasis on mission‑critical software, AI, fintech, biotech.
• Vi Partners leverages two‑decade network across Europe.
• Hands‑on approach aims to build category‑defining companies.

Pulse Analysis

Switzerland’s venture capital landscape has matured into a credible alternative to traditional hubs like Silicon Valley, and Vi Partners stands as a cornerstone of that evolution. Celebrating a quarter‑century of activity, the firm’s latest €161 million fund underscores the durability of its investment thesis and the depth of its relationships with entrepreneurs, corporates, and limited partners. This milestone not only reflects a consistent track record of backing category‑defining companies but also signals a broader confidence in the region’s capacity to generate scalable, technology‑driven growth.

The new vehicle zeroes in on Series A and early‑stage opportunities across both technology and healthcare, sectors where Vi Partners has historically excelled. By targeting mission‑critical software, AI platforms, fintech solutions, and industrial applications, the fund addresses a financing gap for startups that need more than seed capital but are not yet ready for later‑stage rounds. In healthcare, the emphasis on biotech, medtech, and digital health aligns with Europe’s strong research base and regulatory environment, offering portfolio companies a blend of capital, sector expertise, and a hands‑on partnership model that can accelerate product development and market entry.

For investors, the fund presents a differentiated exposure to high‑growth European innovators backed by a manager with a proven hands‑on approach and a deep network. As competition for quality deals intensifies, Vi Partners’ long‑term, sector‑focused strategy may deliver attractive risk‑adjusted returns while reinforcing the continent’s innovation ecosystem. The fund’s success could catalyze further capital inflows, encouraging more limited partners to allocate resources to Swiss and broader European venture markets, and ultimately shaping the next generation of global tech and health leaders.

Deal Summary

Swiss venture capital firm Vi Partners announced the first close of its latest fund, targeting €161 million (CHF 150 million). The fund will focus on Series A and early‑stage investments in technology and healthcare, including AI, fintech, biotech, and medtech. The announcement coincides with Vi Partners' 25th anniversary.